A carregar...
EXTH-65. BET INHIBITION IN COMBINATION WITH TEMOZOLOMIDE TARGETS MYCN-POSITIVE GLIOBLASTOMA CELLS
Glioblastoma (GBM) is the most common malignant brain tumor in adults with a 15 month median survival after diagnosis. Patients receive surgical resection of the tumor, followed by aggressive radio- and chemotherapy with temozolomide (TMZ). Many human cancers including GBM demonstrate addiction to M...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216216/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.412 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|